OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Chronological Review of Potential Disease-Modifying Therapeutic Strategies for Alzheimer's Disease
Miren Ettcheto, Oriol Busquets, Triana Espinosa-Jiménez, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1286-1299
Closed Access | Times Cited: 13
Miren Ettcheto, Oriol Busquets, Triana Espinosa-Jiménez, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1286-1299
Closed Access | Times Cited: 13
Showing 13 citing articles:
From Diagnosis to Treatment: Recent Advances in Patient-Friendly Biosensors and Implantable Devices
Pei Li, Gunhee Lee, Su Yeong Kim, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 1960-2004
Closed Access | Times Cited: 279
Pei Li, Gunhee Lee, Su Yeong Kim, et al.
ACS Nano (2021) Vol. 15, Iss. 2, pp. 1960-2004
Closed Access | Times Cited: 279
Wearable and implantable bioelectronics as eco‐friendly and patient‐friendly integrated nanoarchitectonics for next‐generation smart healthcare technology
Suhyeon Kim, Seungho Baek, Ronald Sluyter, et al.
EcoMat (2023) Vol. 5, Iss. 8
Open Access | Times Cited: 48
Suhyeon Kim, Seungho Baek, Ronald Sluyter, et al.
EcoMat (2023) Vol. 5, Iss. 8
Open Access | Times Cited: 48
Cerebrospinal fluid: A specific biofluid for the biosensing of Alzheimer's diseases biomarkers
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Arezoo Mirzaie, Hassan Nasrollahpour, Balal Khalilzadeh, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 166, pp. 117174-117174
Closed Access | Times Cited: 17
Advances in the development paradigm of biosample‐based biosensors for early ultrasensitive detection of alzheimer’s disease
Hem Prakash Karki, Yeongseok Jang, Jinmu Jung, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Hem Prakash Karki, Yeongseok Jang, Jinmu Jung, et al.
Journal of Nanobiotechnology (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 35
Recent Advances in Therapeutics for the Treatment of Alzheimer’s Disease
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 5
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2024) Vol. 29, Iss. 21, pp. 5131-5131
Open Access | Times Cited: 5
Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease
E. F. Shevtsova, Andrey V. Maltsev, Darya V. Vinogradova, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 803-827
Closed Access | Times Cited: 31
E. F. Shevtsova, Andrey V. Maltsev, Darya V. Vinogradova, et al.
Medicinal Research Reviews (2020) Vol. 41, Iss. 2, pp. 803-827
Closed Access | Times Cited: 31
Pd‐Catalyzed Difluoromethylations of Aryl Boronic Acids, Halides, and Pseudohalides with ICF 2 H Generated ex Situ
Oliver R. Gedde, Andreas Bonde, Peter I. Golbækdal, et al.
Chemistry - A European Journal (2022) Vol. 28, Iss. 34
Open Access | Times Cited: 14
Oliver R. Gedde, Andreas Bonde, Peter I. Golbækdal, et al.
Chemistry - A European Journal (2022) Vol. 28, Iss. 34
Open Access | Times Cited: 14
Nanofluidic electrochemical sensors for clinical biomarkers detection
Yulin Hu, Cui Hai-shan, Chunmei Yu, et al.
Microchemical Journal (2023) Vol. 193, pp. 109058-109058
Closed Access | Times Cited: 7
Yulin Hu, Cui Hai-shan, Chunmei Yu, et al.
Microchemical Journal (2023) Vol. 193, pp. 109058-109058
Closed Access | Times Cited: 7
Alzheimer's Disease and β-secretase Inhibition: An Update with a Focus on Computer-aided Inhibitor Design
Samuel Chima Ugbaja, Isiaka A. Lawal, Hezekiel M. Kumalo, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 266-285
Closed Access | Times Cited: 17
Samuel Chima Ugbaja, Isiaka A. Lawal, Hezekiel M. Kumalo, et al.
Current Drug Targets (2021) Vol. 23, Iss. 3, pp. 266-285
Closed Access | Times Cited: 17
c-Jun N-Terminal Kinases in Alzheimer’s Disease: A Possible Target for the Modulation of the Earliest Alterations
Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, et al.
Journal of Alzheimer s Disease (2020) Vol. 82, Iss. s1, pp. S127-S139
Closed Access | Times Cited: 8
Oriol Busquets, Antoni Parcerisas, Ester Verdaguer, et al.
Journal of Alzheimer s Disease (2020) Vol. 82, Iss. s1, pp. S127-S139
Closed Access | Times Cited: 8
Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer’s Disease
David Jalali, Justine Anne Guevarra, Luz María Martínez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7022-7022
Open Access | Times Cited: 6
David Jalali, Justine Anne Guevarra, Luz María Martínez, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 13, pp. 7022-7022
Open Access | Times Cited: 6
“Lab-on-a-phone” project: Micro- and nanotechnology-enabled applications for portable miniaturized analytical systems
Seung Goo Lee, Mohammad Zarei
Elsevier eBooks (2022), pp. 375-400
Closed Access | Times Cited: 2
Seung Goo Lee, Mohammad Zarei
Elsevier eBooks (2022), pp. 375-400
Closed Access | Times Cited: 2
New Targets and Strategies of Medical Treatments in Neurological and Neurodegenerative Disorders
Antoni Camins, Carlos Beas‐Zárate
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1233-1234
Closed Access
Antoni Camins, Carlos Beas‐Zárate
Current Pharmaceutical Design (2020) Vol. 26, Iss. 12, pp. 1233-1234
Closed Access
